These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

418 related items for PubMed ID: 1375025

  • 21. [Phospholipid thrombocyte activating factor, its analogs and antagonists: prospects of their use in medicine].
    Kulikov VI, Muzia GI.
    Vestn Akad Med Nauk SSSR; 1991; (10):13-7. PubMed ID: 1801455
    [Abstract] [Full Text] [Related]

  • 22. Platelet-activating factor antagonists decrease the inflammatory nociceptive response in rats.
    Teather LA, Magnusson JE, Wurtman RJ.
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):430-3. PubMed ID: 12373444
    [Abstract] [Full Text] [Related]

  • 23. Triflavin potentiates the antiplatelet activity of platelet activating factor receptor antagonist on activated neutrophil-induced platelet aggregation.
    Lee LW, Peng HC, Ko WC, Hung WC, Su CH, Lin CH, Huang TF, Yen MH, Sheu JR.
    Eur J Pharmacol; 1999 Jan 08; 364(2-3):239-46. PubMed ID: 9932729
    [Abstract] [Full Text] [Related]

  • 24. Influence of aminophylline and ketotifen in comparison to the lipoxygenase inhibitors NDGA and esculetin and the PAF antagonists WEB 2170 [correction of 2107] and BN 52021 on endothelin-1 induced vaso- and bronchoconstriction.
    Lueddeckens G, Becker K, Rappold R, Förster W.
    Prostaglandins Leukot Essent Fatty Acids; 1991 Nov 08; 44(3):155-8. PubMed ID: 1808625
    [Abstract] [Full Text] [Related]

  • 25. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
    Merlos M, Giral M, Balsa D, Ferrando R, Queralt M, Puigdemont A, García-Rafanell J, Forn J.
    J Pharmacol Exp Ther; 1997 Jan 08; 280(1):114-21. PubMed ID: 8996188
    [Abstract] [Full Text] [Related]

  • 26. Effects of platelet-activating factor on ion transport in isolated rat jejunum.
    Hanglow AC, Bienenstock J, Perdue MH.
    Am J Physiol; 1989 Nov 08; 257(5 Pt 1):G845-50. PubMed ID: 2597284
    [Abstract] [Full Text] [Related]

  • 27. Pharmacological study of phospholipase A2-induced histamine release from rat peritoneal mast cells.
    Choi SH, Sakamoto T, Fukutomi O, Inagaki N, Matsuura N, Nagai H, Koda A.
    J Pharmacobiodyn; 1989 Sep 08; 12(9):517-22. PubMed ID: 2482349
    [Abstract] [Full Text] [Related]

  • 28. Species-dependent differences of high affinity [3H]PAF-binding to platelets from humans and pigs and its inhibition by selected antagonists.
    Ostermann G, Lorenz A, Hofmann B, Kertscher HP.
    J Lipid Mediat; 1991 Nov 08; 4(3):289-98. PubMed ID: 1662546
    [Abstract] [Full Text] [Related]

  • 29. Characterization of receptors for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages.
    Stewart AG, Dusting GJ.
    Br J Pharmacol; 1988 Aug 08; 94(4):1225-33. PubMed ID: 2850058
    [Abstract] [Full Text] [Related]

  • 30. Platelet-activating factor (PAF) receptor antagonists inhibit arachidonic acid induced platelet aggregation in rabbit whole blood.
    Ammit AJ, O'Neill C.
    Lipids; 1991 Dec 08; 26(12):1189-92. PubMed ID: 1668116
    [Abstract] [Full Text] [Related]

  • 31. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist.
    Tsunoda H, Sakuma Y, Harada K, Muramoto K, Katayama S, Horie T, Shimomura N, Clark R, Miyazawa S, Okano K.
    Arzneimittelforschung; 1990 Nov 08; 40(11):1201-5. PubMed ID: 2085331
    [Abstract] [Full Text] [Related]

  • 32. [Effects of ketotifen on rabbit platelet aggregation and platelet activating factor formation from rat neutrophils].
    Wang XD, Bian RL.
    Zhongguo Yao Li Xue Bao; 1990 Nov 08; 11(6):524-7. PubMed ID: 2130617
    [Abstract] [Full Text] [Related]

  • 33. Platelet-activating factor (PAF) inhibitory profile of KO-286011 on blood platelets in vitro and in vivo.
    Ostermann G, Hofmann B, Kertscher HP, Till U.
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec 08; 342(6):713-8. PubMed ID: 2096302
    [Abstract] [Full Text] [Related]

  • 34. Sensitization of human neutrophil defense activities through activation of platelet-activating factor receptors by ginkgolide B, a bioactive component of the Ginkgo biloba extract EGB 761.
    Lenoir M, Pedruzzi E, Rais S, Drieu K, Perianin A.
    Biochem Pharmacol; 2002 Apr 01; 63(7):1241-9. PubMed ID: 11960600
    [Abstract] [Full Text] [Related]

  • 35. Platelet activating factor (PAF) antagonists on cytokine induction of iNOS and sPLA2 in immortalized astrocytes (DITNC).
    Wang JH, Sun GY.
    Neurochem Res; 2000 May 01; 25(5):613-9. PubMed ID: 10905622
    [Abstract] [Full Text] [Related]

  • 36. Effect of WEB 2086-BS, an antagonist of platelet-activating factor receptors, on retinal vascularity in diabetic rats.
    de la Cruz JP, Moreno A, Ruiz-Ruiz MI, García-Campos J, Sánchez de la Cuesta F.
    Eur J Pharmacol; 1998 Oct 30; 360(1):37-42. PubMed ID: 9845270
    [Abstract] [Full Text] [Related]

  • 37. A comparison of the actions of platelet activating factor (PAF) antagonists WEB 2170 and WEB 2086 in the horse.
    Foster AP, Cunningham FM, Andrews MJ, Lees P.
    J Vet Pharmacol Ther; 1993 Dec 30; 16(4):477-87. PubMed ID: 8126765
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.